There were no significant differences in sex, resectability at the initiation of treatment for pancreatic cancer, the frequency of TMB-H or MSI-H, PS, the rate of curative resection and the levels of WBC, Hb, Plt, albumin and CA19-9 between the two groups. This evidence concerns the gene ALB and pancreatic neoplasm.